Terms: = Lung cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Treatment
2597 results:
1. Effect of body mass index and cholesterol-rich apolipoprotein-B-containing lipoproteins on clinical outcome in NSCLC patients treated with immune checkpoint inhibitors-based therapy: A retrospective analysis.
Hu Z; Zheng Y; Zheng J; Wang Y; Liao J; Liu Z; Li J; Cui H
Cancer Med; 2024 Jun; 13(11):e7241. PubMed ID: 38819098
[TBL] [Abstract] [Full Text] [Related]
2. [An analysis of disease burden of occupational lung cancer in China from 1990 to 2019].
Ma HJ; Huang SX; Zeng N
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2024 May; 42(5):355-359. PubMed ID: 38802309
[No Abstract] [Full Text] [Related]
3. Prognostic significance of CT-determined sarcopenia in older patients with advanced squamous cell lung cancer treated with programmed death-1 inhibitors.
Ying L; Xu L; Yang J; Zhang Q
Sci Rep; 2024 May; 14(1):12025. PubMed ID: 38797769
[TBL] [Abstract] [Full Text] [Related]
4. Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial.
Cree BAC; Kim HJ; Weinshenker BG; Pittock SJ; Wingerchuk DM; Fujihara K; Paul F; Cutter GR; Marignier R; Green AJ; Aktas O; Hartung HP; She D; Rees W; Smith M; Cimbora D; Katz E; Bennett JL;
Lancet Neurol; 2024 Jun; 23(6):588-602. PubMed ID: 38760098
[TBL] [Abstract] [Full Text] [Related]
5. [Aprospective study of detection and clinical significance of bone marrow tumor cells in small cell lung cancer].
Wang Y; Lu BH; Gao Y; Liu YX; Hu MM; Che NY; Lin HF; Li HX; Zhang HM; Zhang TM
Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):419-427. PubMed ID: 38742355
[No Abstract] [Full Text] [Related]
6. Seven oral traditional Chinese medicine combined with chemotherapy for the treatment of non-small cell lung cancer: a network meta-analysis.
Liu K; Li Q; Lu X; Fan X; Yang Y; Xie W; Kang J; Sun S; Zhao J
Pharm Biol; 2024 Dec; 62(1):404-422. PubMed ID: 38739082
[TBL] [Abstract] [Full Text] [Related]
7. High incidence of lung cancer death after curative endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
Tajiri A; Tsujii Y; Nishida T; Inoue T; Maekawa A; Kitamura S; Yamaguchi S; Nishihara A; Yamada T; Ogiyama H; Murayama Y; Yamamoto S; Egawa S; Uema R; Yoshihara T; Hayashi Y; Takehara T
Cancer Med; 2024 May; 13(9):e7242. PubMed ID: 38733176
[TBL] [Abstract] [Full Text] [Related]
8. Correlation between changes in nutritional status and tumor response in patients receiving immunotherapy for lung cancer (NUTIMMUNO study).
Mahé M; Seegers V; Vansteene D
Support Care Cancer; 2024 Apr; 32(5):312. PubMed ID: 38676729
[TBL] [Abstract] [Full Text] [Related]
9. Non-small cell lung cancer and immune checkpoint inhibitor therapy: does non-alcoholic fatty liver disease have an effect?
Li Y; Gong B; Guo Y; Liu W; Chen C; Jiang S; Pan F; Song J; Yang L; Zhou G
BMC Cancer; 2024 Apr; 24(1):535. PubMed ID: 38671373
[TBL] [Abstract] [Full Text] [Related]
10. Tumor-agnostic transcriptome-based classifier identifies spatial infiltration patterns of CD8+T cells in the tumor microenvironment and predicts clinical outcome in early-phase and late-phase clinical trials.
Roller A; Davydov II; Schwalie PC; Serrano-Serrano ML; Heller A; Staedler N; Ferreira CS; Dietmann G; Klaman I; Valdeolivas A; Korski K; Cannarile MA
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38649280
[TBL] [Abstract] [Full Text] [Related]
11. [cancer survival analysis in Tianjin, 2010 to 2016].
Wang C; Shen CF; Xun LN; Zhang S; Zhang H; Zheng WL; Wang DZ
Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):319-325. PubMed ID: 38644267
[No Abstract] [Full Text] [Related]
12. [Long-term outcome of patients with rectal cancer who achieve complete or near complete clinical responses after neoadjuvant therapy: a multicenter registry study of data from the Chinese Watch and Wait Database].
Zhao YM; Wang WH; Zhang W; Wang L; Li S; Wang JW; Liao LE; Yu GY; Sun Z; Qu YL; Gong Y; Lu Y; Wu T; Li YF; Wang Q; Zhao GH; Xiao Y; Ding PR; Zhang Z; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):372-382. PubMed ID: 38644243
[No Abstract] [Full Text] [Related]
13. Association of the Advanced lung cancer Inflammation Index (ALI) and Gustave Roussy Immune (GRIm) score with immune checkpoint inhibitor efficacy in patients with gastrointestinal and lung cancer.
Jiang H; Li B; Wu M; Wang Q; Li Y
BMC Cancer; 2024 Apr; 24(1):428. PubMed ID: 38589844
[TBL] [Abstract] [Full Text] [Related]
14. Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI.
Povsic TJ; Korjian S; Bahit MC; Chi G; Duffy D; Alexander JH; Vinereanu D; Tricoci P; Mears SJ; Deckelbaum LI; Bonaca M; Ridker PM; Goodman SG; Cornel JH; Lewis BS; Parkhomenko A; Lopes RD; Aylward P; Lincoff AM; Heise M; Sacks F; Nicolau JC; Merkely B; Trebacz J; Libby P; Nicholls SJ; Pocock S; Bhatt DL; Kastelein J; Bode C; Mahaffey KW; Steg PG; Tendera M; Bainey KR; Harrington RA; Mehran R; Duerschmied D; Kingwell BA; Gibson CM;
J Am Coll Cardiol; 2024 Jun; 83(22):2163-2174. PubMed ID: 38588930
[TBL] [Abstract] [Full Text] [Related]
15. Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.
Zhang L; Xiong Y; Zhang J; Feng Y; Xu A
J Transl Med; 2024 Apr; 22(1):330. PubMed ID: 38576019
[TBL] [Abstract] [Full Text] [Related]
16. Comprehensive analysis and validation reveal DEPDC1 as a potential diagnostic biomarker associated with tumor immunity in non-small-cell lung cancer.
Lv M; Li X; Yin Z; Yang H; Zhou B
PLoS One; 2024; 19(4):e0294227. PubMed ID: 38564630
[TBL] [Abstract] [Full Text] [Related]
17. A new updated prognostic index for patients with brain metastases (BMs) treated with palliative whole brain radiotherapy (WBRT) in the era of precision oncology. METASNCore project.
Flores-Paco P; Vargas-Aliaga A; Guevara MG; Lopera I; Ruiz LR; López-Herrero M; Camús JA; López-González J; Inga-Saavedra E; Montero M; Barneto I; Gómez-España MA; Ruiz E; Ruza M; Armenta A; Palacios A; De La Haba-Rodríguez JR; Aranda E
J Neurooncol; 2024 May; 167(3):407-413. PubMed ID: 38539006
[TBL] [Abstract] [Full Text] [Related]
18. The Role of Pharmaceutical Innovation in Clinical Practice Guidelines for Chronic Diseases.
Roach M; Land N; Hernandez J; Rau R; Chou JW; Hickson SS; Rollmann DF; Maclean JR
Int J Clin Pract; 2024; 2024():5877687. PubMed ID: 38505696
[TBL] [Abstract] [Full Text] [Related]
19. Multicenter evaluation of an automated, multiplex, RNA-based molecular assay for detection of ALK, ROS1, RET fusions and MET exon 14 skipping in NSCLC.
Melchior L; Hirschmann A; Hofman P; Bontoux C; Concha A; Mrabet-Dahbi S; Vannuffel P; Watkin E; Putzová M; Scarpino S; Cayre A; Martin P; Stoehr R; Hartmann A
Virchows Arch; 2024 Apr; 484(4):677-686. PubMed ID: 38492039
[TBL] [Abstract] [Full Text] [Related]
20. Feasibility of precision smoking treatment in a low-income community setting: results of a pilot randomized controlled trial in The Southern Community Cohort Study.
Lee SS; Senft Everson N; Sanderson M; Selove R; Blot WJ; King S; Gilliam K; Kundu S; Steinwandel M; Sternlieb SJ; Cai Q; Warren Andersen S; Friedman DL; Connors Kelly E; Fadden MK; Freiberg MS; Wells QS; Canedo J; Tyndale RF; Young RP; Hopkins RJ; Tindle HA
Addict Sci Clin Pract; 2024 Mar; 19(1):16. PubMed ID: 38491559
[TBL] [Abstract] [Full Text] [Related]
[Next]
